Verified public evidence
SmartClover company and team, CerviGuard and DataGems live products, TealGuard and NIS2COMPASS R&D evidence, repositories, screenshots, and commercial model.
Company, product, and research evidence
This page provides public evidence of SmartClover's legal identity, team, business model, live products, screenshots, product stages, repositories, and approved TealGuard and NIS2COMPASS consortium R&D programmes. Numeric clinical KPIs remain gated until cohort definitions and reporting windows are finalized.
What you can verify today
Company, team, and business modelVerify SMARTCLOVER S.R.L., its leadership, product ownership, and B2B software model.CerviGuard product evidenceReview the live MVP/private beta, screenshots, features, documented TRL 6 starting point, and clinician-led boundaries.DataGems product evidenceReview the live synthetic-data product, screenshots, features, exports, and public repository.TealGuard approved R&D programmeReview the consortium, four-module platform, CerviGuard baseline, and TRL 6-to-TRL 9 roadmap.NIS2COMPASS approved R&D programmeReview SmartClover cybersecurity, resilience, and evidence-workflow R&D.Commercial modelReview B2B subscriptions, licensing, SaaS/PaaS deployment, and product-specific integration.
Document status: Current public baselineEvidence baseline updated: 2026-08-30Page reviewed: 2026-08-30Owner: Product + Commercial + Data
Reported outcomes are cohort-specific, method-bounded, and include explicit limitations. KPI percentages will not be published without denominator and date-window context.
Verified product proof
CerviGuard artifacts visitors can inspect today
The current public proof set starts with CerviGuard: live workspace access, public implementation context, product screenshots, and the draft MDR self-assessment.
Live CerviGuard workspaceCurrent product surface available for demo and product-review conversations.Public implementation repositorySource-level context for the CerviGuard workflow product.Product screenshot galleryPublic-safe screenshots showing dashboard and case-intake workflow surfaces.Draft MDR Class I self-assessmentDraft regulatory-positioning artifact; not a final approval claim.
Evidence status
Qualified public evidence
Draft regulatory material, security baseline pages, and methodology notes that require dated context.
Evidence gaps
Clinical outcome percentages, commercial traction metrics, and final regulatory identifiers are not published yet.
Pending metrics
KPI values remain withheld until cohort definitions, denominator rules, and reporting windows are finalized.
Public milestone timeline
2019-2020
First CerviGuard pilot phase
Historical pilot context is summarized here; current public proof starts with the live CerviGuard workspace and product screenshots below.
2022
Research and project track consolidation
Multiple projects and research tracks were finalized before broader platform expansion.
2024
Company launch and platform preparation
Company launch and online product transition are represented by the current public product route, live workspace, and repository links.
2025-2026
Live products and funded R&D expanded
SmartClover launched public CerviGuard and DataGems product surfaces and secured approved non-dilutive consortium R&D financing through TealGuard and NIS2COMPASS.
Pilot context and methodology notes
- Pilot evidence is currently published through milestone and methodology summaries.
- Outcome publication requires fixed cohort windows and approved numerator/denominator definitions.
- Clinicians review AI outputs before confirming follow-up actions.
KPI framework (values pending publication)
| KPI name | Numerator | Denominator | Cohort window | Method | Caveat |
|---|---|---|---|---|---|
| Case review turnaround improvement | Cases completed inside target review window post-deployment | All eligible cases in selected cohort | Pending publication | Pre/post cohort comparison with fixed inclusion criteria | Workflow mix can vary by site |
| Follow-up adherence uplift | Cases with completed follow-up within defined interval | Cases assigned follow-up action | Pending publication | Operational follow-up completion tracking | External care-path variability applies |
| AI-assisted triage agreement rate | Cases where AI support category aligns with clinician final category | Cases containing both AI output and clinician adjudication | Pending publication | Blinded adjudication and reconciliation rules | Not a standalone diagnostic-accuracy claim |